{"id":129624,"date":"2024-06-10T18:55:36","date_gmt":"2024-06-10T16:55:36","guid":{"rendered":"https:\/\/prod1-sb.designtech.space\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\/129624\/"},"modified":"2024-07-04T17:58:51","modified_gmt":"2024-07-04T15:58:51","slug":"new-round-for-betaglue-8-million-euros-from-neva-and-liftt","status":"publish","type":"post","link":"https:\/\/www.startupbusiness.it\/en\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\/129624\/","title":{"rendered":"New round for BetaGlue, 8 million euros from Neva and LIFTT"},"content":{"rendered":"\n<p><strong>BetaGlue Therapeutics a clinical-stage company developing radiotherapy for the personalized treatment of solid tumors, announces that it has closed an \u20ac8 million equity financing round.<\/strong>  The deal involves both existing and new ivnestors and was led by Neva and LIFTT, with participation from FinPosillipo (Petrone Group), Romed and Giovanni Cerutti.<\/p>\n\n<p>BetaGlue, thanks to the recently announced Accelerator EIC Award worth <a href=\"https:\/\/www.startupbusiness.it\/lifescience-10-milioni-per-betaglue-technologies\/119394\/\" target=\"_blank\" rel=\"noopener\">10 million euros in funding<\/a> (including 7.5 million euros in equity) and this investment round, thus raises a total of 18 million euros.<\/p>\n\n<p>The capital will be used to strengthen the team as well as to accelerate and expand the development of its radiotherapy platform, YntraDose aimed at treating various solid tumors.<\/p>\n\n<p><strong>Colin Story, CEO of BetaGlue, comments in a note, &#8220;We appreciate the support of investors who share our passion and vision toward new radiotherapy treatment options aimed at cancer patient groups with limited treatment options.<\/strong> This funding will enable us to advance the pipeline by reaching important development and regulatory milestones.&#8221;<\/p>\n\n<p><strong>Mario Costantini, managing director and chief executive officer of Neva, says, &#8220;We are pleased to have led this investment round in BetaGlue Therapeutics, an Italian company with an international team and a proven track record in the development of medical device technologies.<\/strong>  Neva once again supports companies facing major global challenges, particularly in the life sciences sector. By funding a clinical-stage company like BetaGlue, we are contributing to the battle against cancer.&#8221;<\/p>\n\n<p><strong>Francesca Mongardi, LIFTT project manager, adds, &#8220;This additional investment by LIFTT confirms our confidence in Betaglue&#8217;s innovative radiotherapy solution, which can offer a new treatment for patients with solid tumors with limited options<\/strong>. We recognize the significant advances and innovations introduced by Betaglue, and we are convinced of the substantial potential in terms of the market, by virtue of a proposal that can address unmet clinical needs. We are excited to contribute to the development of a diverse pipeline of therapeutic indications and to support their regulatory process. This aligns perfectly with our commitment to invest in impactful solutions to advance medical science and redefine the standard of care in cancer therapy.&#8221;  <em>(BetaGlue Therapeutics website photo)<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Biotech company developing innovative radiotherapies for the treatment of solid tumors completes raising to total of 18 million euros<\/p>\n","protected":false},"author":125,"featured_media":137821,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1317,1346],"tags":[1143,1137,1321,1136],"companies":[],"journalist":[1517],"class_list":["post-129624","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-funding-news","category-must-read","tag-investments","tag-italy-en","tag-lifescience-en","tag-startup-en-2","journalist-luca-silvestri-en"],"featured_sizes_urls":{"thumbnail":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/Rectangle-7492.jpg","width":150,"height":109,"crop":false,"srcset":false,"alt":""},"large":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/Rectangle-7492.jpg","width":660,"height":478,"crop":false,"srcset":false,"alt":""},"2048x2048":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/Rectangle-7492.jpg","width":660,"height":478,"crop":false,"srcset":false,"alt":""}},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>New round for BetaGlue, 8 million euros from Neva and LIFTT<\/title>\n<meta name=\"description\" content=\"Biotech company developing innovative radiotherapies to treat solid tumors completes raising to 18 million euros\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.startupbusiness.it\/en\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\/129624\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New round for BetaGlue, 8 million euros from Neva and LIFTT\" \/>\n<meta property=\"og:description\" content=\"Biotech company developing innovative radiotherapies to treat solid tumors completes raising to 18 million euros\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.startupbusiness.it\/en\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\/129624\/\" \/>\n<meta property=\"og:site_name\" content=\"Startupbusiness.it\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-10T16:55:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-04T15:58:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/Rectangle-7492.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"660\" \/>\n\t<meta property=\"og:image:height\" content=\"478\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Emil Abirascid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@emilabirascid\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Emil Abirascid\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\\\/129624\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\\\/129624\\\/\"},\"author\":{\"name\":\"Emil Abirascid\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\"},\"headline\":\"New round for BetaGlue, 8 million euros from Neva and LIFTT\",\"datePublished\":\"2024-06-10T16:55:36+00:00\",\"dateModified\":\"2024-07-04T15:58:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\\\/129624\\\/\"},\"wordCount\":358,\"image\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\\\/129624\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/Rectangle-7492.jpg\",\"keywords\":[\"investments\",\"italy\",\"lifescience\",\"startup\"],\"articleSection\":[\"Funding News\",\"Must Read\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\\\/129624\\\/\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\\\/129624\\\/\",\"name\":\"New round for BetaGlue, 8 million euros from Neva and LIFTT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\\\/129624\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\\\/129624\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/Rectangle-7492.jpg\",\"datePublished\":\"2024-06-10T16:55:36+00:00\",\"dateModified\":\"2024-07-04T15:58:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\"},\"description\":\"Biotech company developing innovative radiotherapies to treat solid tumors completes raising to 18 million euros\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\\\/129624\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\\\/129624\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/Rectangle-7492.jpg\",\"contentUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/Rectangle-7492.jpg\",\"width\":660,\"height\":478},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/\",\"name\":\"Startupbusiness.it\",\"description\":\"May the Force be with you!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\",\"name\":\"Emil Abirascid\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"caption\":\"Emil Abirascid\"},\"description\":\"Emil Abirascid (\u30a8\u30df\u30fc\u30eb\u30fb\u30a2\u30d3\u30e9\u30b7\u30c3\u30c9), giornalista, fondatore e direttore di Startupbusiness, il primo magazine sull\u2019ecosistema startup e innovazione italiano. Co-fondatore di Designtech, l\u2019hub di innovazione che avvicina il mondo del design con quello della tecnologia. Advisor di Austrian Business Agency, Emil Banca, Fondazione Symbola, Fondazione Quadrans. Partecipa regolarmente a incontri, convegni, conferenze dedicate all\u2019ecosistema dell\u2019innovazione. E\u2019 stato co-organizzatore degli Italian Innovation Day and Series che si sono svolti dal dal 2016 al 2020 nelle citt\u00e0 di Tokyo in Giappone, Melbourne, Adelaide, Perth, Canberra in Australia e Singapore e co-organizzatore dell\u2019Italy India Innovation Day di AIICP 2021 e 2022. Ha curato il volume \u2018L\u2019innovazione che non ti aspetti. Contesti e visioni per l\u2019impresa\u2019 , l\u2019edizione italiana di \u2018La startup digitale, guida pratica step by step\u2019 e ha scritto la prefazione all\u2019edizione italiana de \u2018La quarta era\u2019 di Byron Reese, ed \u00e8 co-autore di \u2018Cosa e Dove: strategie digitali di ricerca del lavoro\u2019, tutti editi da FrancoAngeli. In passato \u00e8 stato curatore di StartupDigest Italy, coordinatore scientifico del Forum per la Ricerca della Provincia Autonoma di Trento, board member di TechChill Milano advisor di di ScaleIT , ha collaborato con Il Sole 24 Ore \u00e8 stato direttore di Innov\u2019azione, bimestrale edito da Apsti, ha collaborato con Corriere Innovazione ed \u00e8 stato presidente del comitato di selezione del Premio Marzotto e advisor di Cetif-Universit\u00e0 Cattolica Milano.\",\"sameAs\":[\"https:\\\/\\\/www.abirascid.com\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/emilabirascid\",\"https:\\\/\\\/x.com\\\/emilabirascid\"],\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/author\\\/emil-abirascid\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New round for BetaGlue, 8 million euros from Neva and LIFTT","description":"Biotech company developing innovative radiotherapies to treat solid tumors completes raising to 18 million euros","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.startupbusiness.it\/en\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\/129624\/","og_locale":"en_US","og_type":"article","og_title":"New round for BetaGlue, 8 million euros from Neva and LIFTT","og_description":"Biotech company developing innovative radiotherapies to treat solid tumors completes raising to 18 million euros","og_url":"https:\/\/www.startupbusiness.it\/en\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\/129624\/","og_site_name":"Startupbusiness.it","article_published_time":"2024-06-10T16:55:36+00:00","article_modified_time":"2024-07-04T15:58:51+00:00","og_image":[{"width":660,"height":478,"url":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/Rectangle-7492.jpg","type":"image\/jpeg"}],"author":"Emil Abirascid","twitter_card":"summary_large_image","twitter_creator":"@emilabirascid","twitter_misc":{"Written by":"Emil Abirascid","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.startupbusiness.it\/en\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\/129624\/#article","isPartOf":{"@id":"https:\/\/www.startupbusiness.it\/en\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\/129624\/"},"author":{"name":"Emil Abirascid","@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd"},"headline":"New round for BetaGlue, 8 million euros from Neva and LIFTT","datePublished":"2024-06-10T16:55:36+00:00","dateModified":"2024-07-04T15:58:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.startupbusiness.it\/en\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\/129624\/"},"wordCount":358,"image":{"@id":"https:\/\/www.startupbusiness.it\/en\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\/129624\/#primaryimage"},"thumbnailUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/Rectangle-7492.jpg","keywords":["investments","italy","lifescience","startup"],"articleSection":["Funding News","Must Read"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.startupbusiness.it\/en\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\/129624\/","url":"https:\/\/www.startupbusiness.it\/en\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\/129624\/","name":"New round for BetaGlue, 8 million euros from Neva and LIFTT","isPartOf":{"@id":"https:\/\/www.startupbusiness.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.startupbusiness.it\/en\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\/129624\/#primaryimage"},"image":{"@id":"https:\/\/www.startupbusiness.it\/en\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\/129624\/#primaryimage"},"thumbnailUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/Rectangle-7492.jpg","datePublished":"2024-06-10T16:55:36+00:00","dateModified":"2024-07-04T15:58:51+00:00","author":{"@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd"},"description":"Biotech company developing innovative radiotherapies to treat solid tumors completes raising to 18 million euros","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.startupbusiness.it\/en\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\/129624\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.startupbusiness.it\/en\/new-round-for-betaglue-8-million-euros-from-neva-and-liftt\/129624\/#primaryimage","url":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/Rectangle-7492.jpg","contentUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/Rectangle-7492.jpg","width":660,"height":478},{"@type":"WebSite","@id":"https:\/\/www.startupbusiness.it\/en\/#website","url":"https:\/\/www.startupbusiness.it\/en\/","name":"Startupbusiness.it","description":"May the Force be with you!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.startupbusiness.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd","name":"Emil Abirascid","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","caption":"Emil Abirascid"},"description":"Emil Abirascid (\u30a8\u30df\u30fc\u30eb\u30fb\u30a2\u30d3\u30e9\u30b7\u30c3\u30c9), giornalista, fondatore e direttore di Startupbusiness, il primo magazine sull\u2019ecosistema startup e innovazione italiano. Co-fondatore di Designtech, l\u2019hub di innovazione che avvicina il mondo del design con quello della tecnologia. Advisor di Austrian Business Agency, Emil Banca, Fondazione Symbola, Fondazione Quadrans. Partecipa regolarmente a incontri, convegni, conferenze dedicate all\u2019ecosistema dell\u2019innovazione. E\u2019 stato co-organizzatore degli Italian Innovation Day and Series che si sono svolti dal dal 2016 al 2020 nelle citt\u00e0 di Tokyo in Giappone, Melbourne, Adelaide, Perth, Canberra in Australia e Singapore e co-organizzatore dell\u2019Italy India Innovation Day di AIICP 2021 e 2022. Ha curato il volume \u2018L\u2019innovazione che non ti aspetti. Contesti e visioni per l\u2019impresa\u2019 , l\u2019edizione italiana di \u2018La startup digitale, guida pratica step by step\u2019 e ha scritto la prefazione all\u2019edizione italiana de \u2018La quarta era\u2019 di Byron Reese, ed \u00e8 co-autore di \u2018Cosa e Dove: strategie digitali di ricerca del lavoro\u2019, tutti editi da FrancoAngeli. In passato \u00e8 stato curatore di StartupDigest Italy, coordinatore scientifico del Forum per la Ricerca della Provincia Autonoma di Trento, board member di TechChill Milano advisor di di ScaleIT , ha collaborato con Il Sole 24 Ore \u00e8 stato direttore di Innov\u2019azione, bimestrale edito da Apsti, ha collaborato con Corriere Innovazione ed \u00e8 stato presidente del comitato di selezione del Premio Marzotto e advisor di Cetif-Universit\u00e0 Cattolica Milano.","sameAs":["https:\/\/www.abirascid.com\/","https:\/\/www.linkedin.com\/in\/emilabirascid","https:\/\/x.com\/emilabirascid"],"url":"https:\/\/www.startupbusiness.it\/en\/author\/emil-abirascid\/"}]}},"author_name":"Emil Abirascid","categories_names":["Funding News","Must Read"],"_links":{"self":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/129624","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/comments?post=129624"}],"version-history":[{"count":1,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/129624\/revisions"}],"predecessor-version":[{"id":129627,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/129624\/revisions\/129627"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/media\/137821"}],"wp:attachment":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/media?parent=129624"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/categories?post=129624"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/tags?post=129624"},{"taxonomy":"companies","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/companies?post=129624"},{"taxonomy":"journalist","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/journalist?post=129624"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}